Akamine Scott
- SEC CIK
- 0001816720
No open-market purchases or sales filed in the past year.
Current role at each company
- KLRA Kailera Therapeutics, Inc.Chief Legal Officeras of Apr 20, 2026
- CERE Cerevel Therapeutics Holdings, Inc.Chief Legal Officeras of Aug 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Akamine Scott as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CERE Cerevel Therapeutics Holdings, Inc.
Chief Legal Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 (view filing) | Dec 20 | 1 day | Akamine ScottChief Legal Officer | SSale | −7.07K | $41.42 | −$292.9K | −49.4%7.24K after | |
| Dec 7, 2023 (view filing) | Dec 5-7 | 2 days | Akamine ScottChief Legal Officer | SSale | −17.5K | $38.64 | −$676.2K | −97.2%513 after | 2 lots10b5-1 |
| Aug 9, 2022 (view filing) | Aug 8 | 1 day | Akamine ScottChief Legal Officer | SSale | −10.0K | $40.00 | −$400.0K | −100.0%0 after |